phosphotyrosine has been researched along with cytochalasin e in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duncan, LK; Duncan, MD; Harmon, JW | 1 |
| Aoki, M; Ikewaki, N; Inoko, H; Sawada, A; Tamauchi, H; Yamada, A; Yamamoto, R | 1 |
2 other study(ies) available for phosphotyrosine and cytochalasin e
| Article | Year |
|---|---|
Actin disruption inhibits bombesin stimulation of focal adhesion kinase (pp125FAK) in prostate carcinoma.
Topics: Actins; Antineoplastic Agents; Bombesin; Cell Adhesion Molecules; Cell Line; Cytochalasins; Depsipeptides; Enzyme Activation; Enzyme Inhibitors; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Kinetics; Male; Peptides, Cyclic; Phosphorylation; Phosphotyrosine; Prostatic Neoplasms; Protein-Tyrosine Kinases; Tumor Cells, Cultured | 1996 |
A microfilament formation inhibitor, cytochalasin strongly enhances the low-affinity Fc epsilon receptor II (CD23) expression on the human monocyte-like cell line, U937.
Topics: Actin Cytoskeleton; Cell Division; Cell Survival; Cytochalasin B; Cytochalasin D; Cytochalasins; Humans; Phosphorylation; Phosphotyrosine; Protein Biosynthesis; Protein-Tyrosine Kinases; Receptors, IgE; U937 Cells | 2000 |